BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15801632)

  • 1. [The reserve drugs: their safety for children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2005; (1):27-8. PubMed ID: 15801632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI; Kaminskaia GO; Livchane E
    Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance for antitubercular preparations in the tuberculosis treatment of children and adolescents].
    Firsova VA; Mart'ianova EP
    Probl Tuberk; 1980 Oct; (10):47-51. PubMed ID: 7433447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS; Zakharova RI; Absadykova FT
    Probl Tuberk; 1990; (9):40-2. PubMed ID: 2274509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV; Ovsiankina ES
    Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of tuberculosis in children and adolescents with antitubercular drugs of the 2d group].
    Riazanova AI; Paporish SD
    Probl Tuberk; 1969; 47(2):30-3. PubMed ID: 5309605
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary resistance to basic antituberculous drugs in tuberculosis in children.
    Bujko K; Zapasnik-Kobierska MH; Maliszewska Z; Kostrzenski W
    Pol Med Sci Hist Bull; 1966 Apr; 9(2):81-5. PubMed ID: 5295711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial drugs and their tolerance in children with tuberculosis].
    Naubet'iarova AI; Alibakieva GM; Kim LI; Balgabekova BB
    Probl Tuberk; 1988; (12):21-3. PubMed ID: 3266669
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculosis in adolescents: diagnosis, clinical picture, and treatment].
    Firsova VA
    Probl Tuberk; 2003; (3):23-6. PubMed ID: 12744058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa; Rusakova LI
    Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypersensitivity to antituberculous drugs in children].
    Czarnowska B; Rykowska Z; Robakiewicz M; Ciszek J
    Gruzlica; 1968; 37(1):23-9. PubMed ID: 5305153
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity of first-line drugs for treatment of tuberculosis in children: review.
    Frydenberg AR; Graham SM
    Trop Med Int Health; 2009 Nov; 14(11):1329-37. PubMed ID: 19735381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy for tuberculosis in children and adolescents: problems and ways of their solution].
    Ovsiankina ES; Gubkina MF; Kobulashvili MG; Panova LV
    Probl Tuberk Bolezn Legk; 2006; (8):26-9. PubMed ID: 17002054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection].
    Ovsiankina ES; Kasimtseva OV; Vasil'eva IA
    Probl Tuberk Bolezn Legk; 2006; (1):3-6. PubMed ID: 16512175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects in children and adolescents with pulmonary tuberculosis during treatment with 2d series preparations].
    Adamova EA; Beliatskaia NG; Uzbekova AA
    Probl Tuberk; 1970; 48(3):30-4. PubMed ID: 5311414
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of tuberculosis in children and adolescents by single doses of tuberculostatic drugs].
    Gaganova EP; Terterian EA; Neliubina GA; Sipchenko NF; Petrova NF
    Vrach Delo; 1971 Dec; 12():16-7. PubMed ID: 5316433
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of Mycobacterium tuberculosis infection in children with bronchopulmonary diseases and evaluation of its role in the course of disease].
    Klochkova LV; Korol' OI
    Probl Tuberk; 1995; (5):37-9. PubMed ID: 7567891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.